Novocell Hires John West as CEO

Xconomy San Diego — 

Novocell, the San Diego-based developer of stem cell therapies for diabetes, said it has named John West as president, CEO , and a member of its board. West was previously CEO of Solexa, a maker of genome sequencing machines that was sold to San Diego-based Illumina (NASDAQ: ILMN) in 2007 for more than $600 million.